Metagenomi Therapeutics, Inc. (MGX): 8-K filed Jun 10, 2026

Form type

8-K

Filing date

Jun 10, 2026

Accession number

0001193125-26-264392

Filer

Metagenomi Therapeutics, Inc. (CIK 1785279)